NCT00694434

Brief Summary

Evaluation of embryo quality in the fresh cycle as a predictor of outcome from frozen embryo transfer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
183

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2002

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2002

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2007

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 6, 2008

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 10, 2008

Completed
Last Updated

June 10, 2008

Status Verified

June 1, 2008

Enrollment Period

5.9 years

First QC Date

June 6, 2008

Last Update Submit

June 9, 2008

Conditions

Keywords

CryopreservationFrozen embryo transferGraduated Embryo Score

Outcome Measures

Primary Outcomes (1)

  • On-going gestation (beyond 8 wks)

    Fetal heart activity at 8 weeks of gestation

Secondary Outcomes (1)

  • Implantation rate (gestational sacs/ embryos transferred)

    8 weeks of gestation

Study Arms (2)

1

Patients with 2 or more frozen blastocyst that scored GES 70 or better in the fresh cycle.

2

Patients with 2 or more frozen blastocysts scoring GES \<70 in the fresh cycle.

Eligibility Criteria

Age21 Years - 44 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

All IVF patients at our center between 2002 and 2007 with at least 2 frozen blastocysts undergoing frozen embryo transfer.

You may qualify if:

  • frozen blastocysts

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sher Institute for Reproductive Medicine

Las Vegas, Nevada, 89118, United States

Location

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Study Officials

  • Jeffrey D Fisch, M.D.

    Sher Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 6, 2008

First Posted

June 10, 2008

Study Start

January 1, 2002

Primary Completion

December 1, 2007

Study Completion

December 1, 2007

Last Updated

June 10, 2008

Record last verified: 2008-06

Locations